Mutation of SDHB is a cause of hypoxia-related high-altitude paraganglioma

Clinical Cancer Research

Volumn 16, Issue 16, 2010, Pages 4148-4154

  Cerecer Gil, Nidia Y ^a   Figuera, Luis E ^b   Llamas, Francisco J ^a   Lara, Mauricio ^a   Escamilla, José G ^a   Ramos, Ruben ^a   Estrada, Gerardo ^a   Hussain, A Karim ^d   Gaal, José ^c   Korpershoek, Esther ^c   De Krijger, Ronald R ^c   Dinjens, Winand N M ^c   Devilee, Peter ^d   Bayley, Jean Pierre ^d  

^a Instituto Mexicano del Seguro Social   (Netherlands)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE;

ADULT; AGED; ALTITUDE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; PARAGANGLIOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; TUMOR RECURRENCE;

AGED; ALTITUDE; CAROTID BODY TUMOR; CELL HYPOXIA; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PEDIGREE; POLYMERASE CHAIN REACTION; SUCCINATE DEHYDROGENASE;

EID: 77955761570     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-0637     Document Type: Article

References (49)

1. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-51.
2. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-70.
3. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54. (Pubitemid 32614017)
4. Hao HX, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 2009;325:1139-42.
5. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
6. Racker E. History of the Pasteur effect and its pathobiology. Mol Cell Biochem 1974;5:17-23.
7. Belhocine T, Spaepen K, Dusart M, et al. 18FDG PET in oncology: the best and the worst (review). Int J Oncol 2006;28:1249-61.
8. Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;12:1241-52.
9. Bayley JP, Devilee P. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree? Curr Opin Genet Dev 2010;3:324-9.
10. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum Mol Genet 2005;14: 2231-9.
11. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-β prolyl hydroxylase. Cancer Cell 2005;7:77-85.
12. Semenza GL. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr 2007;39:231-4.
13. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates - possible links between cell metabolism and stabilization of HIF. J Biol Chem 2007;282:4524-32. (Pubitemid 47100953)
14. MacKenzie ED, Selak MA, Tennant DA, et al. Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol 2007;27:3282-9.
15. Guzy RD, Sharma B, Bell E, Chandel NS, Schumacker PT. Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol 2008;28:718-31.
16. Slane BG, Aykin-Burns N, Smith BJ, et al. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res 2006;66:7615-20. (Pubitemid 44289218)
17. Smith EH, Janknecht R, Maher LJ III. Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum Mol Genet 2007;16:3136-48. (Pubitemid 350131331)
18. Mansfield KD, Guzy RD, Pan Y, et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab 2005;1:393-9. (Pubitemid 43960625)
19. Arias-Stella J. The carotid body at high altitudes. Meeting Am Assoc Pathol and Bact (Abstract 150) 1969.
20. Edwards C, Heath D, Harris P, Castillo Y, Kruger H, rias-Stella J. The carotid body in animals at high altitude. J Pathol 1971;104:231-8.
21. Arias-Stella J, Valcarcel J. The human carotid body at high altitudes. Pathol Microbiol (Basel) 1973;39:292-7.
22. Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol 1973;4:251-63.
23. Khan Q, Heath D, Smith P, Norboo T. The histology of the carotid bodies in highlanders from Ladakh. Int J Biometeorol 1988;32:254-9.
24. Arias-Stella J, Bustos F. Chronic hypoxia and chemodectomas in bovines at high altitudes. Arch Pathol Lab Med 1976;100:636-9. (Pubitemid 8192973)
25. Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 1998;20:374-8.
26. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 2003;113:228-37. (Pubitemid 36992281)
27. Jech M, varado-Cabrero I, bores-Saavedra J, Dahia PL, Tischler AS. Genetic analysis of high altitude paragangliomas. Endocr Pathol 2006;17:201-2.
28. Bayley JP, Grimbergen AE, van Bunderen PA, et al. The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients. BMC Med Genet 2009;10:34.
29. McDonnell CM, Benn DE, Marsh DJ, Robinson BG, Zacharin MR. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma. Clin Endocrinol (Oxf) 2004;61:510-4.
30. Solis DC, Burnichon N, Timmers HJ, et al. Penetrance and clinical consequences of a gross SDHB deletion in a large family. Clin Genet 2009;75:354-63.
31. Shamblin WR, ReMine WH, Sheps SG, Harrison EG, Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg 1971;122:732-9.
32. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
33. van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 2009;10:764-71.
34. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003;31:3812-4. (Pubitemid 37442253)
35. Sunyaev S, Ramensky V, Koch I, Lathe W III, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001; 10:591-7.
36. Ferrer-Costa C, Orozco M, de lC X. Sequence-based prediction of pathological mutations. Proteins 2004;57:811-9.
37. Bayley JP, Devilee P, Taschner PE. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 2005;6:39. (Pubitemid 41794081)
38. Jansen JC, van den BR, Kuiper A, Van Der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000;88:2811-6.
39. Elshaikh MA, Mahmoud-Ahmed AS, Kinney SE, et al. Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys 2002;52:953-6.
40. Georgiadis GS, Lazarides MK, Tsalkidis A, Argyropoulou P, Giatromanolaki A. Carotid body tumor in a 13-year-old child: case report and review of the literature. J Vasc Surg 2008;47:874-80.
41. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 2006;91:803-6.
42. Powell FL, Fu Z. HIF-1 and ventilatory acclimatization to chronic hypoxia. Respir Physiol Neurobiol 2008;164:282-7.
43. Lee S, Nakamura E, Yang H, et al. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 2005;8:155-67. (Pubitemid 41132744)
44. Kaelin WG, Jr. SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling. Cancer Cell 2009;16:180-2.
45. Favier J, Briere JJ, Burnichon N, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One 2009; 4:e7094.
46. Luna-Ortiz K, Rascon-Ortiz M, Villavicencio-Valencia V, Granados-Garcia M, Herrera-Gomez A. Carotid body tumors: review of a 20-year experience. Oral Oncol 2005;41:56-61. (Pubitemid 39647120)
47. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009;69:3650-6.
48. Pedro-Segura E, Vergara SV, Rodriguez-Navarro S, Parker R, Thiele DJ, Puig S. The Cth2 ARE-binding protein recruits the Dhh1 helicase to promote the decay of succinate dehydrogenase SDH4 mRNA in response to iron deficiency. J Biol Chem 2008;283:28527-35.
49. Van Der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-4.